当前位置:主页 > 医学论文 > 肿瘤论文 >

Bax介导硼替佐米诱导胃癌细胞株MKN45凋亡作用的研究

发布时间:2018-10-31 07:39
【摘要】:目的验证BCl-2相关X(Bax)蛋白在硼替佐米(BTZ)诱导胃癌细胞株MKN45的凋亡作用。方法以人Bax(NC_000019.10)为靶标设计sh RNA序列,将Bax sh RNA转染至MKN45细胞中,G418筛选耐药克隆。荧光定量聚合酶链反应和Western blot测定转染前后Bax m RNA和蛋白含量。给予空载体对照MKN45及sh Bax转染的MKN45细胞BTZ梯度加药(5、25、50、100、250、500和1 000 nmol/L),检测其细胞增殖、凋亡程度。结果通过转染,建立Bax表达稳定下调的MKN45-sh Bax细胞系。给予BTZ梯度加药后,阴性对照(Mock)组胃癌细胞MKN45 Bax含量增加,凋亡程度逐渐增加,增殖率逐渐降低。沉默Bax后BTZ诱导的MKN45细胞凋亡受到抑制,增殖能力增强。结论 Bax能部分介导BTZ对胃癌细胞株MKN45的凋亡作用。
[Abstract]:Objective to investigate the effect of BCl-2 associated X (Bax) protein on the apoptosis of gastric cancer cell line MKN45 induced by bortezomie (BTZ). Methods sh RNA sequence was designed with human Bax (NC_000019.10) as target and Bax sh RNA was transfected into MKN45 cells. Drug resistant clones were screened by G418. Fluorescence quantitative polymerase chain reaction (FQ-PCR) and Western blot were used to determine the content of Bax m RNA and protein before and after transfection. The cell proliferation and apoptosis of MKN45 cells transfected with empty vector MKN45 and sh Bax were detected by BTZ gradient administration (5F2550100250500 and 1 000 nmol/L). Results A stable down-regulated MKN45-sh Bax cell line was established by transfection of Bax. After administration of BTZ gradient, the MKN45 Bax content, apoptosis degree and proliferation rate of gastric cancer cells in negative control (Mock) group were increased, and the proliferation rate was gradually decreased. The apoptosis of MKN45 cells induced by BTZ was inhibited and the proliferation ability was enhanced after silencing Bax. Conclusion Bax can partially mediate the apoptosis of gastric cancer cell line MKN45 by BTZ.
【作者单位】: 中国医科大学附属盛京医院第一肿瘤科;
【基金】:国家自然科学基金(N0:81472806)
【分类号】:R735.2

【相似文献】

相关期刊论文 前10条

1 赵小萍;孙彩虹;;硼替佐米在恶性肿瘤治疗中的应用进展[J];实用肿瘤学杂志;2007年05期

2 王慧涵;廖爱军;刘卓刚;王晓彬;李迎春;杨威;张嵘;张新刚;;硼替佐米联合地塞米松治疗复发及难治性多发性骨髓瘤的临床研究[J];中国医科大学学报;2008年01期

3 吴圣豪;李俊白;郑翠萍;;硼替佐米对混合淋巴细胞培养体系细胞活性影响的研究[J];现代医药卫生;2009年22期

4 李增军;邹德慧;刘庆珍;邱录贵;;硼替佐米治疗继发性浆细胞白血病1例并文献复习[J];临床血液学杂志;2011年05期

5 刘红艳;郭静明;叶松;王海燕;冉昌丽;;自体外周血造血干细胞移植联合硼替佐米治疗原发性系统性淀粉样变性[J];内科急危重症杂志;2012年02期

6 侯健,周帆,张永贞,景燕;硼替佐米治疗复发、难治性多发性骨髓瘤[J];中国新药与临床杂志;2005年07期

7 袁振刚;侯健;周帆;王东星;付卫军;陈玉宝;奚昊;杨盛玲;;硼替佐米联合地塞米松治疗16例复发、难治性多发性骨髓瘤患者[J];中华血液学杂志;2006年10期

8 高冲;陈宝安;孙耘玉;程坚;费菲;;硼替佐米为主方案治疗复发难治性多发性骨髓瘤[J];白血病.淋巴瘤;2007年04期

9 段明辉;周道斌;韩冰;李剑;邹农;张薇;朱铁楠;赵永强;武永吉;;硼替佐米治疗12例难治性多发性骨髓瘤[J];白血病.淋巴瘤;2007年05期

10 谢亚萍;钱R季,

本文编号:2301407


资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/zlx/2301407.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户25176***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com